Immunoreactive Tn is a pancarcinoma epitope resulting from aberrant glycosylation of mucins in primary carcinomas and their metastases; strong Tn epitope expression is associated with poor prognosis. All humans have anti-Tn antibodies, natural anticarcinoma antibodies, predominantly IgM, elicited primarily by their own intestinal flora. Anti-Tn IgM levels were determined by us, using an enzyme-linked immuno-sorbent assay and interrelated to the total IgM of the subject’s serum by the formula: Anti-Tn QMe = 100 × [(Anti-Tn IgM)2/ Total IgM]. Anti-Tn Qus naα! higher sensitivity and comparable specificity to anti-Tn IgM alone in breast carcinoma detection. Anti-Tn QMe results were positive in 79% of the 119 breast carcinoma patients tested; they were negative in 84% of the 32 patients with benign breast disease and in 94% of the 49 healthy controls. Further studies of immune responses to the pathogenetic functions of this marker in carcinoma are indicated.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.